TNGX PEER ANALYSIS

Tango Therapeutics Inc — metric-by-metric comparison with peers and the industry median

TNGXTango Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

TNGXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TNGX	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	30.04	18.00
P/B	11.24	6.26	—	2.25●	3.60
EV/EBITDA	—	118.24	—	10.37●	15.20
P/S	77.19	3.18	30.99	2.67●	10.43

Financial Health
Metric	TNGX	TLX	MSB	CSL	Ind. Median
Current Ratio	27.38●	1.43	—	2.57	5.90
Debt/Equity	8.4%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	3.30	13.13	—	2.22●	1.15

Profitability
Metric	TNGX	TLX	MSB	CSL	Ind. Median
Net Margin	-188.2%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-38.4%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-30.2%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	-184.5%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	TNGX	TLX	MSB	CSL	Ind. Median
Rev. Growth	39.0%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	TNGX	EWTX	VKTX	CRNX	CPRX	ACAD	Ind. Median
P/E	—	—	—	—	18.04	11.95●	18.00
P/B	11.24	10.06	9.20	6.79	3.94	3.60●	3.60
EV/EBITDA	—	—	—	—	9.68●	29.07	15.20
P/S	77.19	—	—	481.00	6.69	4.10●	10.43

Financial Health
Metric	TNGX	EWTX	VKTX	CRNX	CPRX	ACAD	Ind. Median
Current Ratio	27.38●	22.61	5.72	18.60	7.10	3.59	5.90
Debt/Equity	8.4%	0.8%	—	3.7%	0.3%●	4.1%	10.9%
NetDebt/EBITDA	3.30	2.82	—	2.53	-2.25	-6.31●	1.15

Profitability
Metric	TNGX	EWTX	VKTX	CRNX	CPRX	ACAD	Ind. Median
Net Margin	-188.2%	—	—	-2,747.2%	37.1%●	34.3%	-125.7%
ROE	-38.4%	-38.1%	-70.0%	-39.2%	24.5%	37.3%●	-47.5%
ROA	-30.2%	-36.2%	-64.0%	-35.9%	21.5%	27.4%●	-35.8%
EBITDA Margin	-184.5%	—	—	-2,723.4%	56.1%●	11.6%	-105.8%

Growth + Dividend
Metric	TNGX	EWTX	VKTX	CRNX	CPRX	ACAD	Ind. Median
Rev. Growth	39.0%	-100.0%	—	2,277.5%●	11.7%	9.9%	5.1%
NI Growth	—	—	—	—	12.1%	64.1%●	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TNGX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.